FDA Inspection
Berger, Daniel M.D.Berger, Daniel M.D. – FDA Inspection, Nov 24, 2009
Record Details
This FDA Inspection record concerns Berger, Daniel M.D., with an inspection on November 24, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Berger, Daniel M.D.
- Inspection Date
- November 24, 2009
- Product Type
- Drugs
View Company Profile
ID · a04a864c-c7da-423e-a6d3-938d525f3d1b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 638294
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Berger, Daniel M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 4, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 13, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Berger, Daniel M.D.
- FDA Inspection 996685 - 2016-11-15
- FDA Inspection 902528 - 2014-12-04
- FDA Inspection 583659 - 2009-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.